51.82
51.82 (0%)
As of Feb 14, 2025
Ptc Therapeutics, Inc. [PTCT]
Source:
Company Overview
Ptc Therapeutics, Inc is a global biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders.
| Country | United States |
| Headquarters | south plainfield, new jersey |
| Phone Number | 9082227000 |
| Industry | manufacturing |
| CEO | Matthew B. Klein, M.D. |
| Website | ptcbio.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $806.8 |
| Operating Profit | $-302.6 |
| Net Income | |
| Net Cash | $185 |
Profit Ratios
| Gross Margin | $749.4 |
| Operating Margin | -37.5 |
| Profit as % of Revenues | |
| Profit as % of Assets | |
| Profit as % of Stockholder Equity |
Management Effectiveness
| Return on Equity | 33.1% |
| Return on Assets | -21.3% |
| Turnover Ratio | 44.8% |
| EBITA | $-241.8 |
Balance Sheet and Cash Flow Measures
| Total Assets | $1,705 |
| Total Liabilities | $2,803.1 |
| Operating Cash Flow | $-107.7 |
| Investing Cash Flow | $44.2 |
| Financing Cash Flow | $255.9 |
